SAN

88.23

+0.88%↑

MRK1

114.95

-0.39%↓

SHL.DE

46.57

+0.34%↑

ARGX

515.4

+0.98%↑

FRE

44.24

+0.07%↑

SAN

88.23

+0.88%↑

MRK1

114.95

-0.39%↓

SHL.DE

46.57

+0.34%↑

ARGX

515.4

+0.98%↑

FRE

44.24

+0.07%↑

SAN

88.23

+0.88%↑

MRK1

114.95

-0.39%↓

SHL.DE

46.57

+0.34%↑

ARGX

515.4

+0.98%↑

FRE

44.24

+0.07%↑

SAN

88.23

+0.88%↑

MRK1

114.95

-0.39%↓

SHL.DE

46.57

+0.34%↑

ARGX

515.4

+0.98%↑

FRE

44.24

+0.07%↑

SAN

88.23

+0.88%↑

MRK1

114.95

-0.39%↓

SHL.DE

46.57

+0.34%↑

ARGX

515.4

+0.98%↑

FRE

44.24

+0.07%↑

Search

EssilorLuxottica SA

Slēgts

SektorsVeselības aprūpe

248.4 0.93

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

245.2

Max

249.3

Galvenie mērījumi

By Trading Economics

Ienākumi

-372M

993M

Pārdošana

-72M

13B

P/E

Sektora vidējais

47.685

51.198

EPS

2.976

Dividenžu ienesīgums

1.61

Peļņas marža

7.512

Darbinieki

153,498

EBITDA

635M

3.6B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+10.87% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.61%

2.40%

Nākamie ieņēmumi

2025. g. 24. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-8.2B

113B

Iepriekšējā atvēršanas cena

247.47

Iepriekšējā slēgšanas cena

248.4

Ziņu noskaņojums

By Acuity

27%

73%

71 / 380 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

EssilorLuxottica SA Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 30. maijs 06:42 UTC

Iegādes, apvienošanās, pārņemšana

Ray-Ban Maker EssilorLuxottica to Buy Optegra in Medical AI Push

2025. g. 23. apr. 18:17 UTC

Peļņas

Ray-Ban Maker EssilorLuxottica Implements Measures to Weather U.S. Tariffs -- Update

2025. g. 23. apr. 16:36 UTC

Peļņas

Ray-Ban Maker EssilorLuxottica to Implement Measures to Mitigate U.S. Tariffs

2025. g. 12. febr. 18:35 UTC

Peļņas

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

2025. g. 12. febr. 17:32 UTC

Peļņas

Ray-Ban Maker EssilorLuxottica Posts Higher Profit on Sales Growth

2025. g. 5. jūn. 06:04 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica Doesn't Release Financial Details

2025. g. 5. jūn. 06:03 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica: Transaction Is Expected to Close by the End of June

2025. g. 5. jūn. 06:03 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica: A-Look Operates Over 90 Stores Under A-Look, Seen and OWL Banners

2025. g. 5. jūn. 06:02 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica: Deal Aimed Complementing Long-Standing Position in Malaysia

2025. g. 5. jūn. 06:00 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica to Buy A-Look, Seen and OWL Retail Stores in Malaysia

2025. g. 30. maijs 08:58 UTC

Karstas akcijas

Stocks to Watch Friday: Dell, Marvell, Gap, Ulta -- WSJ

2025. g. 30. maijs 06:04 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica: Deal to Close in 2025 Pending Approvals, Customary Closing Conditions

2025. g. 30. maijs 06:03 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica Doesn't Disclose Financial Details

2025. g. 30. maijs 06:02 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica: Acquisition Is Part of Med-Tech Strategy

2025. g. 30. maijs 06:01 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica to Buy Ophthalmology Platform Optegra Clinics

2025. g. 30. maijs 06:00 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica to Buy Optegra Clinics

2025. g. 24. apr. 09:58 UTC

Tirgus saruna
Peļņas

EssilorLuxottica's Main Challenge Is Trade Environment -- Market Talk

2025. g. 24. apr. 09:35 UTC

Tirgus saruna
Peļņas

EssilorLuxottica's Results Show Resilience Given Macroeconomic Woes -- Market Talk

2025. g. 24. apr. 08:11 UTC

Tirgus saruna
Peļņas

EssilorLuxottica Shows Resilience, But Market Might Turn Cautious -- Market Talk

2025. g. 3. apr. 08:00 UTC

Tirgus saruna

European Luxury Companies Fall After Tariffs; Profit Margins Expected to Shrink -- Market Talk

2025. g. 28. marts 08:57 UTC

Tirgus saruna

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

2025. g. 13. febr. 11:05 UTC

Tirgus saruna
Peļņas

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

2025. g. 13. febr. 10:54 UTC

Tirgus saruna
Peļņas

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

2025. g. 13. febr. 08:41 UTC

Tirgus saruna
Peļņas

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

2025. g. 12. febr. 17:05 UTC

Peļņas

EssilorLuxottica Backs Mid-Term Targets

2025. g. 12. febr. 17:05 UTC

Peļņas

EssilorLuxottica 2024 Oper Pft EUR3.45B

2025. g. 12. febr. 17:04 UTC

Peļņas

Analysts Had Seen EssilorLuxottica 2024 Net Pft at EUR2.50B

2025. g. 12. febr. 17:04 UTC

Peļņas

EssilorLuxottica 2024 Net Pft EUR2.36B

2025. g. 12. febr. 17:03 UTC

Peļņas

EssilorLuxottica 2024 Rev EUR26.51B

2025. g. 12. febr. 17:03 UTC

Peļņas

EssilorLuxottica 4Q Rev EUR6.78B

Salīdzinājums

Cenas izmaiņa

EssilorLuxottica SA Prognoze

Cenas mērķis

By TipRanks

10.87% augšup

Prognoze 12 mēnešiem

Vidējais 272.18 EUR  10.87%

Augstākais 300 EUR

Zemākais 240 EUR

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi EssilorLuxottica SA — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

12 ratings

7

Pirkt

5

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

243.3 / 250.9Atbalsts un pretestība

Īstermiņā

Strong Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

71 / 380 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.